Studies show that del(6p) is associated with the development of focal segmental glomerulosclerosis causing dysregulation of VEGF (vascular endothelial growth factor) synthesis caused by the deletion of the E2F3 gene (Figure 4) [73]. The gene discussed is VEGFA; the disease is focal segmental glomerulosclerosis.